Total Payments
$1,625
2024 Payments
$831.60
Companies
24
Transactions
42
Medicare Patients
1,026
Medicare Billing
$203,536
Payment Breakdown by Category
Food & Beverage$1,526 (93.9%)
Education$99.00 (6.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,526 | 41 | 93.9% |
| Education | $99.00 | 1 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $252.01 | 10 | $0 (2024) |
| Stemline Therapeutics Inc. | $198.40 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $124.99 | 1 | $0 (2023) |
| KCI USA, Inc. | $110.89 | 1 | $0 (2021) |
| Genmab U.S., Inc. | $109.84 | 1 | $0 (2024) |
| Incyte Corporation | $99.00 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $97.47 | 1 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $91.51 | 3 | $0 (2024) |
| ABBVIE INC. | $79.29 | 3 | $0 (2024) |
| Gilead Sciences, Inc. | $75.86 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $831.60 | 24 | Daiichi Sankyo Inc. ($224.25) |
| 2023 | $604.26 | 14 | AstraZeneca Pharmaceuticals LP ($124.99) |
| 2022 | $22.52 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($22.52) |
| 2021 | $166.21 | 3 | KCI USA, Inc. ($110.89) |
All Payment Transactions
42 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Oncology | ||||||
| 10/31/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Lilly USA, LLC | JAYPIRCA (Drug) | Food and Beverage | In-kind items and services | $49.96 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $0.67 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $87.10 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $109.84 | General |
| Category: Oncology | ||||||
| 08/09/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $103.85 | General |
| Category: ONCOLOGY | ||||||
| 06/13/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: ONCOLOGY | ||||||
| 06/12/2024 | Secura Bio, Inc. | COPIKTRA (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: ORAL ONCOLOGIC | ||||||
| 05/30/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Genetically Defined Disease | ||||||
| 05/29/2024 | PUMA BIOTECHNOLOGY, INC. | — | Food and Beverage | In-kind items and services | $14.68 | General |
| 05/17/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: Oncology | ||||||
| 05/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: ONCOLOGY | ||||||
| 05/08/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $27.21 | General |
| Category: ONCOLOGY | ||||||
| 05/01/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: ONCOLOGY | ||||||
| 02/27/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: ONCOLOGY | ||||||
| 01/31/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI | Food and Beverage | In-kind items and services | $97.47 | General |
| Category: Oncology | ||||||
| 01/31/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $40.85 | General |
| Category: ONCOLOGY | ||||||
| 01/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Oncology | ||||||
| 01/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2023 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 776 | 5,098 | $544,088 | $111,359 |
| 2022 | 5 | 152 | 2,922 | $288,151 | $59,182 |
| 2021 | 4 | 98 | 356 | $138,616 | $32,996 |
Total Patients
1,026
Total Services
8,376
Medicare Billing
$203,536
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 58 | 3,480 | $308,432 | $61,227 | 19.9% |
| J2357 | Injection, omalizumab, 5 mg | Office | 2023 | 11 | 675 | $91,409 | $19,659 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 144 | 180 | $40,860 | $9,940 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 85 | $31,122 | $6,986 | 22.4% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 60 | 62 | $18,600 | $2,925 | 15.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $6,944 | $1,670 | 24.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 17 | 18 | $9,000 | $1,554 | 17.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $8,085 | $1,291 | 16.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 68 | 99 | $6,336 | $1,025 | 16.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 69 | 130 | $4,680 | $989.30 | 21.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 59 | 112 | $2,240 | $940.80 | 42.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 17 | 19 | $4,750 | $801.41 | 16.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 34 | 58 | $2,900 | $540.06 | 18.6% |
| 85055 | Reticulated (young) platelet measurement | Office | 2023 | 12 | 15 | $2,145 | $525.45 | 24.5% |
| 86304 | Immunologic analysis for detection of tumor antigen, quantitative; ca 125 | Office | 2023 | 14 | 23 | $2,944 | $468.97 | 15.9% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 22 | 24 | $1,440 | $320.64 | 22.3% |
| 83550 | Iron binding capacity | Office | 2023 | 23 | 25 | $875.00 | $214.25 | 24.5% |
| 83540 | Iron level | Office | 2023 | 23 | 25 | $675.00 | $158.50 | 23.5% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 20 | 21 | $651.00 | $124.32 | 19.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 45 | 2,700 | $238,810 | $47,265 | 19.8% |
| 11043 | Removal of muscle and/or tissue, 20.0 sq cm or less | Office | 2022 | 12 | 34 | $22,107 | $4,744 | 21.5% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 20 | 52 | $17,918 | $4,077 | 22.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 17 | 53 | $6,986 | $2,328 | 33.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 58 | 83 | $2,329 | $767.10 | 32.9% |
| 11043 | Removal of skin and/or muscle first 20 sq cm or less | Office | 2021 | 26 | 113 | $73,474 | $17,737 | 24.1% |
About Ramsey Keyes, FNP
Ramsey Keyes, FNP is a Primary Care healthcare provider based in Bedford, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2021. The National Provider Identifier (NPI) number assigned to this provider is 1174194427.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ramsey Keyes, FNP has received a total of $1,625 in payments from pharmaceutical and medical device companies, with $831.60 received in 2024. These payments were reported across 42 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,526).
As a Medicare-enrolled provider, Keyes has provided services to 1,026 Medicare beneficiaries, totaling 8,376 services with total Medicare billing of $203,536. Data is available for 3 years (2021–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Other Specialties Family
- Location Bedford, TX
- Active Since 07/08/2021
- Last Updated 04/05/2023
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1174194427
Products in Payments
- Enhertu (Drug) $252.01
- Orserdu (Drug) $198.40
- ENHERTU (Biological) $124.99
- Cavilon Advanced Skin Protectant (Device) $110.89
- Epkinly (Drug) $109.84
- DARZALEX (Biological) $97.47
- MYRISK (Device) $91.51
- Trodelvy (Drug) $75.86
- Zetuvit Plus (Device) $55.32
- EPKINLY (Drug) $52.63
- JAYPIRCA (Drug) $49.96
- BESREMI (Drug) $34.62
- Nplate (Biological) $27.79
- VENCLEXTA (Drug) $26.66
- Stivarga (Drug) $22.75
- VPRIV (Biological) $22.52
- PYRUKYND (Drug) $21.26
- LIBTAYO (Biological) $20.72
- TEVIMBRA (Drug) $20.43
- COPIKTRA (Drug) $19.76
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Primary Care Doctors in Bedford
Annmarie Jones, Np, NP
Primary Care — Payments: $1,511
Primary Care $1,511
Dr. Binu Bashyal, Aprn, Fnp-C, APRN, FNP-C
Primary Care — Payments: $1,374
Primary Care $1,374
Christine Linert, Fnp-C, FNP-C
Primary Care — Payments: $262.39
Primary Care $262.39
Christina Rebic
Primary Care — Payments: $257.65
Primary Care $257.65
Angela Young
Primary Care — Payments: $168.66
Primary Care $168.66
Mrs. Zamar Raza, M.d, M.D
Primary Care — Payments: $13.90
Primary Care $13.90